Condition: Non-muscle Invasive Bladder Cancer (NMIBC)

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT07187063

Sponsor: Lahey Clinic

Eligibility:

• Age: minimum 18 Years maximum N/A
• Gender: All

Inclusion Criteria:

• AUA high-risk bladder cancer1
• Received induction BCG or gemcitabine/docetaxel
• Negative initial post-induction therapy assessment (negative cytology and cystoscopy +/- biopsy)

Exclusion Criteria:

• High-risk NMIBC within 3 years
• Prior induction intravesical therapy
• Variant histology
• Concurrent upper tract disease

View trial on ClinicalTrials.gov